Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, the COVID-19 pandemic was associated with increased diagnoses of acne and telogen effluvium, particularly among patients with COVID-19, at a New York City hospital system.

This excerpt discusses website navigation and access details for JAMA Dermatology and reports no new research findings.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

In this case report, the authors identified giant cell arteritis as the underlying cause of bitemporal hair loss and scalp tenderness in a 70-year-old woman, initially misdiagnosed as age-related symptoms.

This case report describes a rare instance of tinea capitis caused by Trichophyton tonsurans in a Chinese patient, followed by the development of herpes zoster, suggesting a potential link to immunosuppression.

This study found that mycophenolate mofetil is effective for both induction and maintenance therapy in children with severe lupus nephritis, significantly improving proteinuria and antibody levels, without renal flares during maintenance.

This review discusses various skin reactions after SARS-CoV-2 infection and COVID-19 vaccination, noting a higher incidence with mRNA vaccines than adenovirus vector vaccines, and reports no new clinical results.

This review discusses the various skin manifestations of COVID-19, aiming to improve early detection and treatment but reports no new clinical results.

In this study, a possible case of Wolf’s isotopic response was observed, where a 72-year-old woman developed superficial basal cell carcinoma at a prior herpes zoster site on her scalp, possibly due to altered local immunity from the zoster episode.

This case study documents a rare concurrent presentation of herpes zoster and alopecia areata in a 24-year-old male, highlighting transient alopecia as a cutaneous complication of varicella zoster infection and suggesting further research into the virus's effect on dormant hair follicles.

In this case series, Xiang Chen reported instances of nail damage and hair loss following herpes zoster, noting the need for further exploration into the mechanisms and potential risk factors such as tuberculosis infection and kidney transplantation.

In this study conducted at a tertiary care center, rural elderly patients often exhibited skin conditions like wrinkling, generalized pruritus, xerosis, eczematous skin conditions, and psoriasis, highlighting the need for better health education on skin care, early diagnosis, and management.

This study reports that ritlecitinib, when used for up to 24 months in patients aged 12 and older with alopecia areata, has an acceptable safety profile, with a similar proportion of adverse events in both ritlecitinib and placebo groups in the placebo-controlled cohort.

This study describes common skin disorders in palliative care patients, emphasizing that conditions like xerosis, pressure ulcers, and fungal infections often require symptomatic treatment focused on quality of life rather than cure, due to limited life expectancy and potential treatment burdens.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

This study suggests that varicella-zoster virus infection in skin cells may play a role in segmental vitiligo's progression and depigmentation.

This case report describes a rare association where herpes zoster infection may have triggered the first attack of NMOSD with systemic vasculitis in a patient, suggesting potential overlaps in immunopathogenesis.

This study observed that the COVID-19 pandemic altered the distribution of dermatological diseases, with increased cases of conditions like scabies and telogen effluvium, while acne and psoriasis cases decreased.

This research aims to evaluate the impact of the COVID-19 post-crisis period and normalization process on dermatology practice, suggesting implications for future healthcare challenges; no new results are reported.

This study found an increase in certain dermatological conditions like dermatitis and scabies, and a decrease in others such as psoriasis vulgaris and atopic dermatitis during the COVID-19 pandemic compared to the previous year.

The document concludes that scalp conditions have various causes and can present in many different ways.

In Ethiopia, this study found that certain skin and mucous membrane disorders, particularly oral conditions, were statistically related to HIV infection and may assist in early detection of the disease.

This review explores the roles of histamine receptors H2R, H3R, and H4R in treating various dermatoses but reports no new clinical outcomes.

In this study, white females with Ludwig I female pattern hair loss had significantly higher hair density on the occipital scalp area, while Asian females had significantly thicker hair diameters in both frontal and occipital areas.

Philippine stingless bee propolis may promote hair growth and fight cancer.

This case report describes a 4-year-old girl in Singapore with inflammatory tinea capitis, which improved with oral griseofulvin and selenium sulfide shampoo.

This article discusses the implementation of problem-based learning in a ninth-grade biology class in Singapore, highlighting the use of authentic, student-driven inquiries to explore topics like nutrition and health without reporting new empirical results.

This article discusses the low cost of hair transplant procedures in India compared to countries like Singapore, Canada, and Australia, noting that the choice of city and method affects prices.

This article discusses the surveillance and spread of hand, foot, and mouth disease in China, Singapore, and Indonesia, and reports no new results, emphasizing the need for improved prevention and management strategies.

Japanese researchers created new hair follicles from human cells that grew hair when put into mice, and other findings showed a link between eye disease severity and corneal thickness, gene mutations affecting hearing and touch, and the safety of the shingles vaccine for adults over 50.